What is the catalog number for CD45/PTPRC Rabbit Polyclonal Antibody?

The catalog number for CD45/PTPRC Rabbit Polyclonal Antibody is orb196266.

What sizes are available for CD45/PTPRC Rabbit Polyclonal Antibody?

CD45/PTPRC Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is CD45/PTPRC Rabbit Polyclonal Antibody in stock?

CD45/PTPRC Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

CD45/PTPRC Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Receptor-type tyrosine-protein phosphatase C; 3.1.3.48; Leukocyte common antigen; L-CA; T200; CD45; PTPRC; CD45

UniProt

P08575

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human CD45 recombinant protein (Position: R1113-S1304) . Human CD45 shares 68% amino acid (aa) sequence identity with both mouse and rat CD45.

Target

Receptor-type tyrosine-protein phosphatase C

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cell Biology, Disease Biomarkers, Immunology & Inflammation, Protein Biochemistry, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human Immunofluorescence, 2μg/ml, Human Flow Cytometry (Fixed), 1-3μg/1x10^6 cells, Human

Form

Lyophilized

Molecular Weight

180-250 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, IF, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.